Subcutaneous Methylnaltrexone Provides Long-Term Laxation in Patients with Chronic Non-Malignant Pain and Opioid-Induced Constipation

被引:0
|
作者
Webster, L. R. [1 ]
Michna, E. [2 ]
Khan, A. [3 ]
Maller, E. [4 ]
Tzanis, E. [4 ]
Israel, R. [5 ]
机构
[1] Lifetree Clin Res & Pain Clin, Salt Lake City, UT USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] NW Clin Res, Bellevue, WA USA
[4] Wyeth Res, Collegeville, PA USA
[5] Progen Pharmaceut Inc, Tarrytown, NY USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
153
引用
收藏
页码:44 / 44
页数:1
相关论文
共 50 条
  • [21] Methylnaltrexone for opioid-induced constipation in patients at the end of life
    Santucci, Gina
    Battista, Vanessa
    International Journal of Palliative Nursing, 2015, 21 (04) : 162 - 164
  • [22] Efficacy and safety of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain: a placebo crossover analysis
    Viscusi, E.
    Barrett, A.
    Paterson, C.
    Forbes, W.
    JOURNAL OF PAIN, 2014, 15 (04): : S88 - S88
  • [23] Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain
    Webster, L.
    Peppin, J.
    Harper, J.
    Israel, R.
    JOURNAL OF PAIN, 2016, 17 (04): : S94 - S94
  • [24] Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain A Placebo Crossover Analysis
    Viscusi, Eugene R.
    Barrett, Andrew C.
    Paterson, Craig
    Forbes, William P.
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2016, 41 (01) : 93 - 98
  • [25] Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain
    Webster, Lynn R.
    Israel, Robert J.
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 1503 - 1510
  • [26] Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer
    Chamberlain, Bruce H.
    Rhiner, Michelle
    Slatkin, Neal E.
    Stambler, Nancy
    Israel, Robert J.
    PAIN MANAGEMENT, 2020, 10 (02) : 73 - 84
  • [27] Efficacy and safety of subcutaneous methylnaltrexone in advanced illness patients with opioid-induced constipation: a responder analysis
    Nalamachu, S.
    Pergolizzi, J.
    Taylor, R.
    Slatkin, N.
    Barrett, A.
    Yu, J.
    Bortey, E.
    Paterson, C.
    Forbes, W.
    JOURNAL OF PAIN, 2013, 14 (04): : S62 - S62
  • [28] Effect of Methylnaltrexone on Anorectal Function in Patients with Opioid-induced Constipation
    Tuteja, Ashok
    Grandemange, Andrew
    Waddoups, Lindsey
    Stoddard, Gregory
    Tolman, Keith
    Lipman, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S500 - S501
  • [29] Management of Opioid-Induced Constipation in Cancer Patients Focus on Methylnaltrexone
    Gatti, Antonio
    Sabato, Alessandro Fabrizio
    CLINICAL DRUG INVESTIGATION, 2012, 32 (05) : 293 - 301
  • [30] Methylnaltrexone in the treatment of opioid-induced constipation in patients with advanced illness
    Thomas, Jay
    JOURNAL OF PALLIATIVE CARE, 2007, 23 (03) : 217 - 217